2021
DOI: 10.21203/rs.3.rs-455083/v1 View full text |Buy / Rent full text
Preprint
|
|

Abstract: Preclinical studies have revealed that the elevation of nicotinamide adenine dinucleotide (NAD+) levels on administration of an NAD+ precursor, nicotinamide mononucleotide (NMN), can mitigate aging-related disorders; however, human data are sparse. Therefore, we aimed to investigate whether the chronic oral supplementation of NMN can elevate blood NAD+ levels and alter physiological dysfunctions, including muscle weakness, in healthy elderly participants. We administered 250 mg NMN per day to aged men for 6 or… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
1
0

Publication Types

Select...

Relationship

0
0

Authors

Journals